Induced Pluripotent Stem Cells Generated Without Viral Integration
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Pluripotent stem cells have been generated from mouse and human somatic cells by viral expression of the transcription factors Oct4, Sox2, Klf4, and c-Myc. A major limitation of this technology is the use of potentially harmful genome-integrating viruses. We generated mouse induced pluripotent stem (iPS) cells from fibroblasts and liver cells by using nonintegrating adenoviruses transiently expressing Oct4, Sox2, Klf4, and c-Myc. These adenoviral iPS (adeno-iPS) cells show DNA demethylation characteristic of reprogrammed cells, express endogenous pluripotency genes, form teratomas, and contribute to multiple tissues, including the germ line, in chimeric mice. Our results provide strong evidence that insertional mutagenesis is not required for in vitro reprogramming. Adenoviral reprogramming may provide an improved method for generating and studying patient-specific stem cells and for comparing embryonic stem cells and iPS cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Adenovirus and Sendai virus-mediated vector delivery provide alternative non-integrative methods for iPSC reprogramming [24,25,26,27,28].”
From Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies (2023) · cites this paper as [24]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Generation of germline-competent induced pluripotent stem cells
Okita, K., Ichisaka, T., & Yamanaka, S. (2007) · Nature · doi:10.1038/nature05934 · Cited by 4,299
In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state
Wernig, M., Meissner, A., Foreman, R., Brambrink, T., Ku, M., Hochedlinger, K., Bernstein, B. E., & Jaenisch, R. (2007) · Nature · doi:10.1038/nature05944 · Cited by 2,676
Self-citationReprogramming of human somatic cells to pluripotency with defined factors
Park, I.-H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., Lerou, P. H., Lensch, M. W., & Daley, G. Q. (2008) · Nature · doi:10.1038/nature06534 · Cited by 2,436
Maherali, N., Sridharan, R., Xie, W., Utikal, J., Eminli, S., Arnold, K., Stadtfeld, M., Yachechko, R., Tchieu, J., Jaenisch, R., et al. (2007) · Cell stem cell · doi:10.1016/j.stem.2007.05.014 · Cited by 1,725
Self-citationHuangfu, D., Maehr, R., Guo, W., Eijkelenboom, A., Snitow, M., Chen, A. E., & Melton, D. A. (2008) · Nature Biotechnology · doi:10.1038/nbt1418 · Cited by 1,606
Dissecting direct reprogramming through integrative genomic analysis
Mikkelsen, T. S., Hanna, J., Zhang, X., Ku, M., Wernig, M., Schorderet, P., Bernstein, B. E., Jaenisch, R., Lander, E. S., & Meissner, A. (2008) · Nature · doi:10.1038/nature07056 · Cited by 1,480
Wernig, M., Zhao, J.-P., Pruszak, J., Hedlund, E., Fu, D., Soldner, F., Broccoli, V., Constantine-Paton, M., Isacson, O., & Jaenisch, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801677105 · Cited by 1,216
Research works printed but not linked: 1
- S. Eminli J. Utikal K. Arnold R. Jaenisch K. Hochedlinger Stem Cells published online 17June2008 in press.
Cited by
Items 601–700 of 1,002
Das, A. K., & Pal, R. (2010) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.258 · Cited by 34
Reprogramming of Somatic Cells to Pluripotency
Nakagawa, M., & Yamanaka, S. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-7037-4_14 · Cited by 34
Wang, C., Zhu, K., Li, J., Lai, H., Wang, C., & Lai, H. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s73961 · Cited by 34
Induced neural stem cells (iNSCs) in neurodegenerative diseases
Hermann, A., & Storch, A. (2013) · Journal of Neural Transmission · doi:10.1007/s00702-013-1042-9 · Cited by 34
A new era of disease modeling and drug discovery using induced pluripotent stem cells
Suh, W. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0871-0 · Cited by 34
Burns, J. C., Yoo, J. J., Atala, A., & Jackson, J. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048704 · Cited by 34
Induced Pluripotency of Mouse and Human Somatic Cells
Aherali, N. M., & Ochedlinger, K. H. (2008) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2008.73.017 · Cited by 34
Griscelli, F., Féraud, O., Oudrhiri, N., Gobbo, E., Casal, I., Chomel, J., Bièche, I., Duvillard, P., Opolon, P., Turhan, A. G., et al. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.01.011 · Cited by 33
Reprogramming Human Retinal Pigmented Epithelial Cells to Neurons Using Recombinant Proteins
Hu, Q., Chen, R., Teesalu, T., Ruoslahti, E. I., & Clegg, D. (2014) · Stem Cells Translational Medicine · doi:10.5966/sctm.2014-0038 · Cited by 33
Induced pluripotent stem (iPS) cells from human fetal stem cells (hFSCs)
Spinelli, V., Guillot, P. V., & Coppi, P. D. (2013) · Organogenesis · doi:10.4161/org.25197 · Cited by 33
Pfaff, N., Lachmann, N., Kohlscheen, S., Sgodda, M., Araúzo-Bravo, M. J., Greber, B., Kues, W. A., Glage, S., Baum, C., Niemann, H., et al. (2011) · Stem Cells and Development · doi:10.1089/scd.2011.0010 · Cited by 33
Development of Lung Epithelium from Induced Pluripotent Stem Cells
Ghaedi, M., Niklason, L. E., & Williams, J. C. (2015) · Current Transplantation Reports · doi:10.1007/s40472-014-0039-0 · Cited by 33
Induced Pluripotent Reprogramming from Promiscuous Human Stemness‐Related Factors
Nelson, T. J., Martinez‐Fernandez, A., Yamada, S., Mael, A. A., Terzic, A., & Ikeda, Y. (2009) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2009.00091.x · Cited by 33
Human-Induced Pluripotent Stem Cells: In Quest of Clinical Applications
Madonna, R. (2012) · Molecular Biotechnology · doi:10.1007/s12033-012-9504-0 · Cited by 33
Regenerative medicine in urology
Wezel, F., Southgate, J., & Thomas, D. F. M. (2011) · British Journal of Urology · doi:10.1111/j.1464-410x.2011.10206.x · Cited by 33
POU transcription factors in melanocytes and melanoma
Besch, R., & Berking, C. (2013) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2013.10.001 · Cited by 33
Transcription factor induced conversion of human fibroblasts towards the hair cell lineage
Alonso, M. B. D., López‐Hernández, I., de la Fuente, M. Á., García-Sancho, J., Giráldez, F., & Schimmang, T. (2018) · PLoS ONE · doi:10.1371/journal.pone.0200210 · Cited by 33
Liver regeneration microenvironment of hepatocellular carcinoma for prevention and therapy
Li, H., & Zhang, L. (2016) · Oncotarget · doi:10.18632/oncotarget.12101 · Cited by 32
Chen, H., Zuo, Q., Wang, Y., Song, J., Yang, H., Zhang, Y., & Li, B. (2017) · BMC Biotechnology · doi:10.1186/s12896-017-0336-7 · Cited by 32
Induction of tissue-specific stem cells by reprogramming factors, and tissue-specific selection
Noguchi, H., Saitoh, I., Tsugata, T., Kataoka, H. U., Watanabe, M., & Noguchi, Y. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.132 · Cited by 32
Li, C., Yu, H., Ma, Y., Shi, G., Jiang, J., Gu, J., Yang, Y., Jin, S., Wei, Z., Jiang, H. L., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006724 · Cited by 32
Salvianolic acid B–vitamin C synergy in cardiac differentiation from embryonic stem cells
Chan, S. S.-K., Chen, J.-H., Hwang, S., Wang, I.-J., Li, H., Lee, R. T., & Hsieh, P. C. H. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.07.122 · Cited by 32
Pfannkuche, K., Fatima, A., Gupta, M. K., Dieterich, R., & Hescheler, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009580 · Cited by 32
Zhang, S., Sun, J., Pan, S., Zhu, H., Wang, L., Hu, Y. H., Wang, J., Wang, F., Cao, H., Yan, X., et al. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23029 · Cited by 32
Tang, L., Yin, Y., Haole, Z., Song, G., Fan, A., Tang, B., Shi, W., & Li, Z. (2012) · Cellular Reprogramming · doi:10.1089/cell.2011.0098 · Cited by 32
The Interface of Gene Editing with Regenerative Medicine
Farag, V., Devey, E. A., & Leong, K. W. (2024) · Engineering · doi:10.1016/j.eng.2024.10.019 · Cited by 31
Porcine induced pluripotent stem cells may bridge the gap between mouse and human iPS
Esteban, M. A., Peng, M., Zhang, D., Cai, J., Yang, J., Xu, J., Lai, L., & Pei, D. (2010) · IUBMB Life · doi:10.1002/iub.307 · Cited by 31
Verfaillie, C. M. (2009) · Transfusion Clinique et Biologique · doi:10.1016/j.tracli.2009.04.006 · Cited by 31
Stem Cells on Biomaterials for Synthetic Grafts to Promote Vascular Healing
Babczyk, P., Conzendorf, C., Klose, J., Schulze, M., Harre, K., & Tobiasch, E. (2014) · Journal of Clinical Medicine · doi:10.3390/jcm3010039 · Cited by 31
Nuzzi, R., & Tridico, F. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00494 · Cited by 31
New approaches for the generation of induced pluripotent stem cells
Sidhu, K. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2011.558837 · Cited by 31
Jaiswal, M. K. (2017) · Neural Regeneration Research · doi:10.4103/1673-5374.206635 · Cited by 31
Stem cell biology and cell transplantation therapy in the retina
Osakada, F., Hirami, Y., & Takahashi, M. (2009) · Biotechnology and Genetic Engineering Reviews · doi:10.5661/bger-26-297 · Cited by 31
Okada, M., & Yoneda, Y. (2010) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2010.10.004 · Cited by 31
Imaging of Induced Pluripotent Stem Cells: From Cellular Reprogramming to Transplantation.
Cai, W., Zhang⋆, Y., & Kamp, T. J. (2011) · Europe PMC (PubMed Central) · Cited by 31
Zhang, R., Liu, T.-Y., Senju, S., Haruta, M., Hirosawa, N., Suzuki, M., Tatsumi, M., Ueda, N., Maki, H., Nakatsuka, R., et al. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0117 · Cited by 31
Liu, S., Fu, R., Wu, D., Hsu, C.-Y., Chang, C., Lee, W., Lee, Y.-D., Liu, C. H., Chien, Y.-J., Lin, S., et al. (2013) · Stem Cells and Development · doi:10.1089/scd.2013.0182 · Cited by 31
Li, Y., Zhao, H., Lan, F., Lee, A. S., Chen, L., Lin, C., Yao, Y., & Li, L. (2010) · Cellular Reprogramming · doi:10.1089/cell.2009.0103 · Cited by 31
Sequential multi-molecule delivery using vortex-assisted electroporation
Yun, H., & Hur, S. C. (2013) · Lab on a Chip · doi:10.1039/c3lc50196e · Cited by 31
Yalcinkaya, T. M., Sittadjody, S., & Opara, E. C. (2013) · Maturitas · doi:10.1016/j.maturitas.2013.10.007 · Cited by 31
Weltner, J., Anisimov, A., Alitalo, K. K., Otonkoski, T., & Trokovic, R. (2012) · Journal of Virology · doi:10.1128/jvi.06302-11 · Cited by 30
Zhang, W., Jiao, B., Zhou, M., Zhou, T., & Shen, L. H. (2016) · Stem Cells International · doi:10.1155/2016/7828049 · Cited by 30
Gheibi, S., Singh, T., da Cunha, J. P. M. C. M., Fex, M., & Mulder, H. (2020) · Cells · doi:10.3390/cells9112465 · Cited by 30
Repair of the CNS Using Endogenous and Transplanted Neural Stem Cells
Trueman, R. C., Klein, A., Lindgren, H. S., Lelos, M. J., & Dunnett, S. B. (2012) · Current topics in behavioral neurosciences · doi:10.1007/7854_2012_223 · Cited by 30
Current status and future directions of clinical applications using iPS cells—focus on Japan
Tsujimoto, H., & Osafune, K. (2021) · FEBS Journal · doi:10.1111/febs.16162 · Cited by 30
From skin to the treatment of diseases - the possibilities of iPS cell research in dermatology
Galach, M., & Utikal, J. S. (2011) · Experimental Dermatology · doi:10.1111/j.1600-0625.2011.01282.x · Cited by 30
Self-citationA comprehensive analysis of induced pluripotent stem cell (iPSC) production and applications
Matiukhova, M., Ryapolova, A., Andriianov, V. S., Reshetnikov, V. V., Zhuravleva, S., Ivanov, R. A., Karabelsky, A. V., & Minskaia, E. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1593207 · Cited by 30
Biofabrication of tissue engineering vascular systems
Zhang, Q., Bosch-Rué, È., Pérez, R. A., & Truskey, G. A. (2021) · APL Bioengineering · doi:10.1063/5.0039628 · Cited by 30
The Cardiogenic Niche as a Fundamental Building Block of Engineered Myocardium
Christalla, P., Hudson, J. E., & Zimmermann, W. (2011) · Cells Tissues Organs · doi:10.1159/000331407 · Cited by 30
Direct somatic lineage conversion
Tanabe, K., Haag, D., & Wernig, M. (2015) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2014.0368 · Cited by 30
Posttranslational Modifications of Defined Embryonic Reprogramming Transcription Factors
Ramakrishna, S., Kim, K., & Baek, K. (2014) · Cellular Reprogramming · doi:10.1089/cell.2013.0077 · Cited by 30
Development of pluripotent stem cells for vascular therapy
Volz, K. S., Miljan, E., Khoo, A., & Cooke, J. P. (2012) · Vascular Pharmacology · doi:10.1016/j.vph.2012.02.010 · Cited by 30
Trosko, J. E., & Kang, K. (2012) · International Journal of Stem Cells · doi:10.15283/ijsc.2012.5.1.39 · Cited by 30
Young, J. S., Morshed, R. A., Kim, J. W., Balyasnikova, I. V., Ahmed, A. U., & Lesniak, M. S. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.937420 · Cited by 30
Induced pluripotent stem cells: a new tool for toxicology screening?
Heng, B. C., Richards, M., Shu, Y., & Gribbon, P. M. (2009) · Archives of Toxicology · doi:10.1007/s00204-009-0414-2 · Cited by 30
iPS Cells in Type 1 Diabetes Research and Treatment
Maehr, R. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.1 · Cited by 30
An induced pluripotent stem cell-mediated and integration-free factor VIII expression system
Yakura, Y., Ishihara, C., Kurosaki, H., Kazuki, Y., Komatsu, N., Okada, Y., Doi, T., Takeya, H., & Oshimura, M. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.12.096 · Cited by 30
The regulation of human embryo and stem-cell research in the United Kingdom
Lovell-Badge, R. H. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2550 · Cited by 30
Rowntree, R. K., & McNeish, J. D. (2010) · Regenerative Medicine · doi:10.2217/rme.10.36 · Cited by 29
Future alternative therapies for β-thalassemia
Rivella, S., & Rachmilewitz, E. A. (2009) · Expert Review of Hematology · doi:10.1586/ehm.09.56 · Cited by 29
Dissecting microRNA-mediated regulation of stemness, reprogramming, and pluripotency
Lee, Y. J., Ramakrishna, S., Chauhan, H., Park, W. S., Hong, S., & Kim, K.-S. (2016) · Cell Regeneration · doi:10.1186/s13619-016-0028-0 · Cited by 29
Induced pluripotent stem cells (iPSCs)—a new era of reprogramming
Kang, L., Kou, Z., Zhang, Y., & Gao, S. (2010) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/s1673-8527(09)60060-6 · Cited by 29
Dierickx, P., Doevendans, P. A., Geijsen, N., & Laake, L. W. V. (2012) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9391-6 · Cited by 29
Types and Classification of Stem Cells
Shah, A. A., & Khan, F. A. (2021) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-030-78101-9_2 · Cited by 29
Stem cells and the treatment of Parkinson's disease
Ali, F. R., Stott, S., & Barker, R. A. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2012.12.017 · Cited by 29
Xie, Y., & Zhang, R. X. (2014) · Neurological Sciences · doi:10.1007/s10072-014-1989-9 · Cited by 29
Transduction of Cell-Penetrating Peptides into Induced Pluripotent Stem Cells
Yukawa, H., Noguchi, H., Nakase, I., Miyamoto, Y., Oishi, K., Hamajima, N., Futaki, S., & Hayashi, S. (2010) · Cell Transplantation · doi:10.3727/096368910x509031 · Cited by 29
Efficient Induction of Pluripotent Stem Cells from Menstrual Blood
Li, Y., Li, X., Zhao, H., Feng, R., Zhang, X., Tai, D., An, G., Wen, J., & Tan, J. (2012) · Stem Cells and Development · doi:10.1089/scd.2012.0428 · Cited by 29
Induced pluripotent stem cells in research and therapy.
Teoh, H.-K., & Cheong, S. (2012) · PubMed · Cited by 29
Induced Pluripotency and Gene Editing in Disease Modelling: Perspectives and Challenges
Seah, S., Farran, C. A. E., Warrier, T., Xu, J., & Loh, Y. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161226119 · Cited by 28
Modeling Schizophrenia Using Induced Pluripotent Stem Cell–Derived and Fibroblast-Induced Neurons
Tran, N., Ladran, I., & Brennand, K. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs127 · Cited by 28
The integrative aspects of cardiac physiology and their implications for cell‐based therapy
Pijnappels, D. A., Grégoire, S., & Wu, S. M. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05077.x · Cited by 28
Generation of pluripotent stem cells via protein transduction
Li, X., Zhang, P., Wei, C., & Zhang, Y. (2014) · The International Journal of Developmental Biology · doi:10.1387/ijdb.140007xl · Cited by 28
Deubiquitylating enzymes as cancer stem cell therapeutics
Haq, S., Suresh, B., & Ramakrishna, S. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.10.004 · Cited by 28
Cardiac Regeneration with Human Pluripotent Stem Cell-Derived Cardiomyocytes
Park, M., & Yoon, Y. (2018) · Korean Circulation Journal · doi:10.4070/kcj.2018.0312 · Cited by 28
Possible Strategies to Reduce the Tumorigenic Risk of Reprogrammed Normal and Cancer Cells
Lin, Y., Ku, C., Wuputra, K., Liu, C., Wu, D., Satou, M., Mitsui, Y., Saito, S., & Yokoyama, K. K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105177 · Cited by 28
Technological Progress in Generation of Induced Pluripotent Stem Cells for Clinical Applications
Oh, S.-I., Lee, C. K., Cho, K. J., Lee, K.-O., Cho, S., & Hong, S. (2012) · The Scientific World JOURNAL · doi:10.1100/2012/417809 · Cited by 28
Cell reprogramming approaches in gene- and cell-based therapies for Parkinson's disease
Man, J. H. K., Groenink, L., & Caiazzo, M. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.07.017 · Cited by 28
Stem cells and chronic wound healing: state of the art
Lorenz, H. P., Leavitt, T., Hu, M. S.-M., Marshall, C. D., Barnes, L. A., & Longaker, M. T. (2016) · Chronic Wound Care Management and Research · doi:10.2147/cwcmr.s84369 · Cited by 28
Approaches for immunological tolerance induction to stem cell-derived cell replacement therapies
Boyd, A. S., & Fairchild, P. J. (2010) · Expert Review of Clinical Immunology · doi:10.1586/eci.10.20 · Cited by 28
Diagnostic value and safety of long-term video-EEG monitoring.
Hui, A. C.-F., Kwan, P., Leung, T. W. H., Soo, Y. O. Y., Mok, V., & Wong, K. S. (2007) · PubMed · Cited by 28
Sümer, H., Jones, K. L., Liu, J., Heffernan, C., Tat, P. A., Upton, K. R., & Verma, P. J. (2010) · Stem Cells and Development · doi:10.1089/scd.2009.0142 · Cited by 28
Gene Therapy: Implications for Craniofacial Regeneration
Scheller, E. L., Villa-Diaz, L. G., & Krebsbach, P. H. (2012) · Journal of Craniofacial Surgery · doi:10.1097/scs.0b013e318241dc11 · Cited by 28
Research status and prospect of stem cells in the treatment of diabetes mellitus
Liu, X., Wang, Y., Li, Y., & Pei, X. (2013) · Science China Life Sciences · doi:10.1007/s11427-013-4469-1 · Cited by 28
Tour d’horizon des lignées de cellules souches pluripotentes
Kieffer, E., Kuntz, S., & Viville, S. (2010) · médecine/sciences · doi:10.1051/medsci/20102610848 · Cited by 28
Moral Complicity in Induced Pluripotent Stem Cell Research
Brown, M. T. (2009) · Kennedy Institute of Ethics journal · doi:10.1353/ken.0.0270 · Cited by 28
The Application of Human iPSCs in Neurological Diseases: From Bench to Bedside
Xie, N., & Tang, B. (2016) · Stem Cells International · doi:10.1155/2016/6484713 · Cited by 27
Yan, Q., Quan, Y., Sun, H., Peng, X., Zou, Z., Alcorn, J. L., Wetsel, R. A., & Wang, D. (2014) · Stem Cells · doi:10.1002/stem.1570 · Cited by 27
Application Prospect of Induced Pluripotent Stem Cells in Organoids and Cell Therapy
Zhang, T., Qian, C., Song, M., Tang, Y., Zhou, Y., Dong, G., Shen, Q., Chen, W., Wang, A., Shen, S., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052680 · Cited by 27
Regenerative Medicine Approaches in Bioengineering Female Reproductive Tissues
Sittadjody, S., Criswell, T. L., Jackson, J. D., Atala, A., & Yoo, J. J. (2021) · Reproductive Sciences · doi:10.1007/s43032-021-00548-9 · Cited by 27
Generation and characterization of bat-induced pluripotent stem cells
Mo, X., Li, N., & Wu, S. (2014) · Theriogenology · doi:10.1016/j.theriogenology.2014.04.001 · Cited by 27
Differentiation of Pluripotent Stem Cells into Retinal Pigmented Epithelium
Croze, R. H., & Clegg, D. (2014) · Developments in ophthalmology · doi:10.1159/000357361 · Cited by 27
iPS Cells—The Triumphs and Tribulations
Sharma, R. (2016) · Dentistry Journal · doi:10.3390/dj4020019 · Cited by 27
Manufacturing blood ex vivo: a futuristic approach to deal with the supply and safety concerns
Singh, V. K., Saini, A., Tsuji, K., Sharma, P., & Chandra, R. (2014) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2014.00026 · Cited by 27
Ben‐Reuven, L., & Reiner, O. (2016) · Development Growth & Differentiation · doi:10.1111/dgd.12280 · Cited by 27
Defining pluripotent stem cells through quantitative proteomic analysis
Reiland, S., Salekdeh, G. H., & Krijgsveld, J. (2011) · Expert Review of Proteomics · doi:10.1586/epr.10.100 · Cited by 27
Clinical Grade iPS Cells: Need for Versatile Small Molecules and Optimal Cell Sources
Wu, Y., Pandian, G. N., Ding, Y., Zhang, W., Tanaka, Y., & Sugiyama, H. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.09.016 · Cited by 27
Making HSCs in vitro: don’t forget the hemogenic endothelium
Blaser, B. W., & Zon, L. I. (2018) · Blood · doi:10.1182/blood-2018-04-784140 · Cited by 27
Teng, H. F., Li, P. N., Hou, D., Liu, S. W., Lin, C. T., Loo, M. R., Kao, C. H., Lin, K., & Chen, S. L. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.12.008 · Cited by 27
Biswas, A., Liu, Y., Liu, T., Fan, G., & Tang, Y. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.04.012 · Cited by 27
Metadata
- Authors
- Stadtfeld, M., Nagaya, M., Utikal, J., Weir, G., & Hochedlinger, K.
- Affiliations
- Joslin Diabetes Center (US)
- Corresponding author
- Hochedlinger, Konrad
- Venue
- Science
- Published
- 2008-11-07
- Volume
- 322
- Issue
- 5903
- Pages
- 945-949
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC3987909
- OpenAlex
- W2050689355
- Cited by
- 1,683
- References
- 29
- Citations by year
- 2026: 12 · 2025: 13 · 2024: 33 · 2023: 22 · 2022: 32 · 2021: 55 · 2020: 50 · 2019: 38 · 2018: 63 · 2017: 63 · 2016: 104 · 2015: 105 · 2014: 139 · 2013: 161 · 2012: 185
- FWCI
- 82.28
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (1dp2od003266-01)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Animal Genetics and Reproduction
- Keywords
- induced pluripotent stem cells, Oct4, SOX2, KLF4, c-Myc, somatic cell reprogramming, DNA demethylation, teratoma, chimeric mice, fibroblasts, hepatocytes, insertional mutagenesis, patient-derived stem cells, embryonic stem cells
- MeSH terms
- Kruppel-Like Factor 4, Adenoviridae, Animals, Cell Differentiation, Cell Line, Chimera, Cloning, Molecular, Female, Fibroblasts, Genetic Vectors, Liver, Male, Teratoma, Genes, myc, Proto-Oncogene Proteins c-myc, Mice, SCID, Virus Integration, Transgenes, Hepatocytes, Pluripotent Stem Cells, Octamer Transcription Factor-3, Mice, Kruppel-Like Transcription Factors, SOXB1 Transcription Factors, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.